butorphanol has been researched along with neuropeptide y in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Billington, CJ; Grace, MK; Jewett, DC; Jones, RM; Levine, AS; Portoghese, PS | 1 |
Billington, CJ; Grace, MK; Kim, EM; Kotz, CM; Kuskowski, MA; Levine, AS; Mitra, A | 1 |
2 other study(ies) available for butorphanol and neuropeptide y
Article | Year |
---|---|
The kappa-opioid antagonist GNTI reduces U50,488-, DAMGO-, and deprivation-induced feeding, but not butorphanol- and neuropeptide Y-induced feeding in rats.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Brain; Butorphanol; Drug Interactions; Eating; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Food Deprivation; Guanidines; Male; Morphinans; Naltrexone; Narcotic Antagonists; Narcotics; Neuropeptide Y; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa | 2001 |
Effects of butorphanol on feeding and neuropeptide Y in the rat.
Topics: Analgesics, Opioid; Animals; Appetite Stimulants; Arcuate Nucleus of Hypothalamus; Behavior, Animal; Butorphanol; Dose-Response Relationship, Drug; Energy Intake; Food Deprivation; Gene Expression Regulation; Male; Narcotic Antagonists; Nerve Tissue Proteins; Neurons; Neuropeptide Y; Organ Specificity; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tachyphylaxis | 2012 |